002422 科伦药业
已收盘 09-30 15:00:00
资讯
新帖
简况
9月21日科伦药业涨6.81%，中欧医疗健康混合A基金重仓该股
证券之星 · 09-21
9月21日科伦药业涨6.81%，中欧医疗健康混合A基金重仓该股
科伦药业涨6.81%，东海证券一周前给出“买入”评级
证券之星 · 09-21
科伦药业涨6.81%，东海证券一周前给出“买入”评级
科伦博泰市值为何反超母公司？
蓝鲸财经 · 09-19
科伦博泰市值为何反超母公司？
9月15日科伦药业现1笔大宗交易 机构净卖出5747.68万元
证券之星 · 09-15
9月15日科伦药业现1笔大宗交易 机构净卖出5747.68万元
9月14日科伦药业涨5.16%，中欧医疗健康混合A基金重仓该股
证券之星 · 09-14
9月14日科伦药业涨5.16%，中欧医疗健康混合A基金重仓该股
科伦药业涨5.16%，东海证券六日前给出“买入”评级
证券之星 · 09-14
科伦药业涨5.16%，东海证券六日前给出“买入”评级
瑞银：中国制药股上半年业绩好坏参半 首选先声药业
同花顺 · 09-09
瑞银：中国制药股上半年业绩好坏参半 首选先声药业
东海证券：给予科伦药业买入评级
证券之星 · 09-08
东海证券：给予科伦药业买入评级
科伦药业新注册《科伦药业员工电子档案系统1.0》项目的软件著作权
证券之星 · 09-08
科伦药业新注册《科伦药业员工电子档案系统1.0》项目的软件著作权
摩根士丹利将科伦药业评级上调至超配，目标价61元。
格隆汇 · 09-03
摩根士丹利将科伦药业评级上调至超配，目标价61元。
科伦药业新注册《科伦药业SAP仓库管理移动终端系统V3.0》项目的软件著作权
证券之星 · 09-03
科伦药业新注册《科伦药业SAP仓库管理移动终端系统V3.0》项目的软件著作权
科伦药业（002422）披露回购公司股份进展公告，9月1日股价上涨0.62%
证券之星 · 09-01
科伦药业（002422）披露回购公司股份进展公告，9月1日股价上涨0.62%
科伦药业（002422）股东刘革新质押882万股，占总股本0.56%
证券之星 · 09-01
科伦药业（002422）股东刘革新质押882万股，占总股本0.56%
股市必读：科伦药业新发布《关于公司控股股东部分股份质押及解除质押的公告》
证券之星 · 08-31
股市必读：科伦药业新发布《关于公司控股股东部分股份质押及解除质押的公告》
科伦药业（002422）股东刘革新质押1429万股，占总股本0.9%
证券之星 · 08-29
科伦药业（002422）股东刘革新质押1429万股，占总股本0.9%
科伦药业：东北证券、汇添富基金等多家机构于8月27日调研我司
证券之星 · 08-28
科伦药业：东北证券、汇添富基金等多家机构于8月27日调研我司
科伦药业（002422）披露控股股东部分股份质押及解除质押公告，8月28日股价下跌1.25%
证券之星 · 08-28
科伦药业（002422）披露控股股东部分股份质押及解除质押公告，8月28日股价下跌1.25%
科伦药业（002422）2026年中报简析：净利润同比增长12.71%
证券之星 · 08-28
科伦药业（002422）2026年中报简析：净利润同比增长12.71%
股市必读：科伦药业新发布《关于“质量回报双提升”行动方案的进展公告》
证券之星 · 08-27
股市必读：科伦药业新发布《关于“质量回报双提升”行动方案的进展公告》
科伦药业最新公告：上半年净利润11.28亿元同比增长12.71%
证券之星 · 08-26
科伦药业最新公告：上半年净利润11.28亿元同比增长12.71%
加载更多
公司概况
公司名称：
四川科伦药业股份有限公司
所属行业：
医药制造业
上市日期：
2010-06-03
主营业务：
四川科伦药业股份有限公司的主营业务是大容量注射剂（输液）、小容量注射剂（水针）、注射用无菌粉针（含分装粉针及冻干粉针）、片剂、胶囊剂、颗粒剂、口服液、腹膜透析液等27种剂型药品及中间体、原料药、医药包材等产品的研发、生产和销售。公司的主要产品是大容量注射剂（输液）、小容量注射剂（水针）、注射用无菌粉针（含分装粉针及冻干粉针）、片剂、胶囊剂、颗粒剂、口服液、腹膜透析液。公司位列“中国医药制造业百强”和“中国制造业500强”，荣登“中国化药企业百强”和“BigPharma企业创新力十强”等榜单。
发行价格：
83.36
{"stockData":{"symbol":"002422","market":"SZ","secType":"STK","nameCN":"科伦药业","latestPrice":40.85,"timestamp":1790751783000,"preClose":39.22,"halted":0,"volume":23676739,"delay":0,"changeRate":0.0416,"floatShares":1299000000,"shares":1591000000,"eps":1.1498,"marketStatus":"已收盘","change":1.63,"latestTime":"09-30 15:00:00","open":38.97,"high":41.7,"low":38.96,"amount":964000000,"amplitude":0.0699,"askPrice":40.85,"askSize":1110,"bidPrice":40.84,"bidSize":5,"shortable":0,"etf":0,"ttmEps":1.1498,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":5,"adr":0,"adjPreClose":39.22,"symbolType":"stock","openAndCloseTimeList":[[1790731800000,1790739000000],[1790744400000,1790751600000]],"highLimit":43.14,"lowLimit":35.3,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1590781208,"isCdr":false,"pbRate":2.53,"roa":"--","peRate":35.527918,"roe":"4.59%","epsLYR":1.07,"committee":-0.573446,"marketValue":64983000000,"turnoverRate":0.0182,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-08。","floatMarketCap":53046000000},"requestUrl":"/m/hq/s/002422","defaultTab":"news","newsList":[{"id":"2669243159","title":"9月21日科伦药业涨6.81%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669243159","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669243159?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:44","pubTimestamp":1789980296,"startTime":"0","endTime":"0","summary":"证券之星消息，9月21日科伦药业涨6.81%，收盘报42.48元，换手率2.86%，成交量37.15万手，成交额15.56亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共154家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为127.36亿元，最新净值1.9645，较上一交易日上涨0.67%，近一年下跌5.53%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100020984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","LU1934453819.USD","002422","LU2148510915.USD","LU1064130708.USD","159760","BK0239","LU1064131003.USD","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159298","title":"科伦药业涨6.81%，东海证券一周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669159298?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:44","pubTimestamp":1789980287,"startTime":"0","endTime":"0","summary":"今日科伦药业涨6.81%，收盘报42.48元。2026年9月8日，东海证券研究员杜永宏发布了对科伦药业的研报《公司简评报告：收入端逐渐企稳，创新药快速放量》，该研报对科伦药业给出“买入”评级。公司大输液结构持续优化，创新药快速放量，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为国盛证券的应沁心。科伦药业个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100020981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668977592","title":"科伦博泰市值为何反超母公司？","url":"https://stock-news.laohu8.com/highlight/detail?id=2668977592","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668977592?lang=zh_cn&edition=full","pubTime":"2026-09-19 14:11","pubTimestamp":1789798262,"startTime":"0","endTime":"0","summary":"值得注意的是，科伦博泰的核心技术平台、生产产能、核心人才体系均依托母公司赋能搭建，母公司更是手握超半数股权，理论上完全享有创新资产的增值红利。商业化步入正轨，但盈利质量尚待验证科伦博泰2026年上半年的归母净利润为3.88亿元，扣除以权益结算的股份支付后的经调整净利润为4.79亿元，实现上市后首次转正。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789368221046307034","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["06990","LU1064131003.USD","LU0196878994.USD","LU1064130708.USD","LU2148510915.USD","LU1934453819.USD","BK0239","BK1161","BK0060","LU1979443071.USD","002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643487","title":"9月15日科伦药业现1笔大宗交易 机构净卖出5747.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643487","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667643487?lang=zh_cn&edition=full","pubTime":"2026-09-15 17:33","pubTimestamp":1789464798,"startTime":"0","endTime":"0","summary":"证券之星消息，9月15日科伦药业发生大宗交易，交易数据如下：大宗交易成交价格40.65元，成交141.39万股，成交金额5747.68万元，买方营业部为国泰海通证券股份有限公司深圳深南大道京基一百证券营业部，卖方营业部为机构专用。近三个月该股共发生9笔大宗交易，合计成交12.99万手，折价成交3笔。截至2026年9月15日收盘，科伦药业报收于40.65元，下跌1.76%，换手率0.85%，成交量10.98万手，成交额4.49亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500027834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU1064131003.USD","LU1979443071.USD","LU2148510915.USD","BK0239","LU1934453819.USD","BK0060","002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667065901","title":"9月14日科伦药业涨5.16%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667065901","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667065901?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:39","pubTimestamp":1789375143,"startTime":"0","endTime":"0","summary":"证券之星消息，9月14日科伦药业涨5.16%，收盘报41.38元，换手率1.71%，成交量22.22万手，成交额9.04亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共154家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为127.36亿元，最新净值1.8588，较上一交易日下跌2.06%，近一年下跌9.56%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU2148510915.USD","BK0060","LU1064131003.USD","159760","LU1934453819.USD","BK0239","002422","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659295","title":"科伦药业涨5.16%，东海证券六日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659295","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667659295?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:38","pubTimestamp":1789375133,"startTime":"0","endTime":"0","summary":"今日科伦药业涨5.16%，收盘报41.38元。2026年9月8日，东海证券研究员杜永宏发布了对科伦药业的研报《公司简评报告：收入端逐渐企稳，创新药快速放量》，该研报对科伦药业给出“买入”评级。公司大输液结构持续优化，创新药快速放量，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为国盛证券的应沁心。科伦药业个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400021165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002422","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666831405","title":"瑞银：中国制药股上半年业绩好坏参半 首选先声药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2666831405","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666831405?lang=zh_cn&edition=full","pubTime":"2026-09-09 15:58","pubTimestamp":1788940680,"startTime":"0","endTime":"0","summary":"瑞银发布研报称，中国制药股上半年业绩好坏参半，在九家评级的制药公司中，有五家业绩好过市场预期，分别为翰森制药(03692)、先声药业(02096)、中国生物制药(01177)、石药集团(01093)及科伦 ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260909/c679739404.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260909/c679739404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["LU1979443071.USD","BK0196","LU1969619763.USD","LU1064130708.USD","002422","BK0187","BK0132","BK0060","LU1064131003.USD","000963","BK0188","BK0239","LU2328871848.SGD","BK0209","LU2148510915.USD","BK0183","LU1934453819.USD","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665228583","title":"东海证券：给予科伦药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2665228583","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665228583?lang=zh_cn&edition=full","pubTime":"2026-09-08 18:51","pubTimestamp":1788864708,"startTime":"0","endTime":"0","summary":"东海证券股份有限公司杜永宏近期对科伦药业进行研究并发布了研究报告《公司简评报告：收入端逐渐企稳，创新药快速放量》，给予科伦药业买入评级。公司大输液结构持续优化，创新药快速放量，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有8家机构给出评级，买入评级7家，中性评级1家；过去90天内机构目标均价为45.93。本文数据来源于东海证券股份有限公司，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800029565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665331094","title":"科伦药业新注册《科伦药业员工电子档案系统1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2665331094","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665331094?lang=zh_cn&edition=full","pubTime":"2026-09-08 02:15","pubTimestamp":1788804916,"startTime":"0","endTime":"0","summary":"证券之星消息，近日科伦药业（002422）新注册了《科伦药业员工电子档案系统1.0》项目的软件著作权。今年以来科伦药业新注册软件著作权4个。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了12.13亿元，同比增15.69%。通过天眼查大数据分析，四川科伦药业股份有限公司共对外投资了47家企业，参与招投标项目8384次；财产线索方面有商标信息1209条，专利信息2081条，著作权信息19条；此外企业还拥有行政许可1370个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800000691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159180","LU1064131003.USD","LU1064130708.USD","LU2148510915.USD","LU1934453819.USD","BK0239","BK0060","LU1979443071.USD","002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827136","title":"摩根士丹利将科伦药业评级上调至超配，目标价61元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827136","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664827136?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:17","pubTimestamp":1788423429,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1064131003.USD","002422","LU1934453819.USD","BK0239","LU1064130708.USD","LU1979443071.USD","LU2148510915.USD","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664284541","title":"科伦药业新注册《科伦药业SAP仓库管理移动终端系统V3.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2664284541","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664284541?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:16","pubTimestamp":1788372974,"startTime":"0","endTime":"0","summary":"证券之星消息，近日科伦药业（002422）新注册了《科伦药业SAP仓库管理移动终端系统V3.0》项目的软件著作权。今年以来科伦药业新注册软件著作权3个。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了12.13亿元，同比增15.69%。通过天眼查大数据分析，四川科伦药业股份有限公司共对外投资了47家企业，参与招投标项目8380次；财产线索方面有商标信息1209条，专利信息2081条，著作权信息18条；此外企业还拥有行政许可1368个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1979443071.USD","LU1064131003.USD","159180","LU1934453819.USD","002422","LU2148510915.USD","BK0239","BK0060","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664852919","title":"科伦药业（002422）披露回购公司股份进展公告，9月1日股价上涨0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664852919","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664852919?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:08","pubTimestamp":1788271717,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，科伦药业报收于40.83元，较前一交易日上涨0.62%，最新总市值为649.52亿元。该股当日开盘40.7元，最高41.1元，最低40.05元，成交额达7.37亿元，换手率为1.4%。近日，科伦药业发布《关于回购公司股份进展的公告》。本次回购符合相关法律法规及既定方案。公司后续将根据市场情况继续实施回购，并履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100042409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002422","BK0060","BK0239","LU1064130708.USD","LU1934453819.USD","LU1064131003.USD","LU2148510915.USD","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664858700","title":"科伦药业（002422）股东刘革新质押882万股，占总股本0.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664858700","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664858700?lang=zh_cn&edition=full","pubTime":"2026-09-01 18:27","pubTimestamp":1788258455,"startTime":"0","endTime":"0","summary":"证券之星消息，科伦药业9月1日公开信息显示，股东刘革新向华泰证券(上海)资产管理有限公司合计质押882.0万股，占总股本0.56%。质押详情见下表：截止本公告日，股东刘革新已累计质押股份8463.0万股，占其持股总数的22.32%，股东雅安市国有资产经营有限责任公司已累计质押股份3089.0万股，占其持股总数的32.93%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100034937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","LU1979443071.USD","LU1934453819.USD","LU1064131003.USD","BK0239","002422","LU2148510915.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663804257","title":"股市必读：科伦药业新发布《关于公司控股股东部分股份质押及解除质押的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663804257","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663804257?lang=zh_cn&edition=full","pubTime":"2026-08-31 01:15","pubTimestamp":1788110110,"startTime":"0","endTime":"0","summary":"公司公告汇总：控股股东刘革新先生解除质押1500万股、新质押1429万股，累计质押股份占其所持股份比例为23.29%，无平仓风险，不导致实际控制人变更。公司公告汇总关于公司控股股东部分股份质押及解除质押的公告四川科伦药业股份有限公司控股股东刘革新先生近日办理部分股份解除质押及新质押业务：本次解除质押15,000,000股，占其所持股份比例3.96%，占公司总股本0.94%；同时新质押14,290,000股，占其所持股份3.77%，占公司总股本0.90%，质押用途为个人资金需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100000576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","LU1064130708.USD","LU2148510915.USD","LU1934453819.USD","BK0239","BK0060","LU1979443071.USD","002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663901330","title":"科伦药业（002422）股东刘革新质押1429万股，占总股本0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663901330","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663901330?lang=zh_cn&edition=full","pubTime":"2026-08-29 00:21","pubTimestamp":1787934096,"startTime":"0","endTime":"0","summary":"证券之星消息，科伦药业8月29日公开信息显示，股东刘革新向华泰证券(上海)资产管理有限公司合计质押1429.0万股，占总股本0.9%。质押详情见下表：截止本公告日，股东刘革新已累计质押股份8831.0万股，占其持股总数的23.29%，股东雅安市国有资产经营有限责任公司已累计质押股份3089.0万股，占其持股总数的32.93%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900001047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU1979443071.USD","LU2148510915.USD","LU1934453819.USD","BK0060","BK0239","002422","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662099767","title":"科伦药业：东北证券、汇添富基金等多家机构于8月27日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2662099767","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662099767?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:20","pubTimestamp":1787926835,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年8月28日科伦药业发布公告称东北证券、汇添富基金、华创证券、华泰证券、华西证券、嘉实基金、开源证券、摩根士丹利、南方基金、申万宏源、UBS、东方财富、西部证券、西南证券、银河证券、浙商证券、中金公司、中泰证券、中信建投、中信证券、中国平安、东方证券、东吴证券、方正证券、富国基金、广发证券、国联民生证券、国泰海通于2026年8月27日调研我司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800054634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002422","BK0028","BK0276","LU1064130708.USD","LU2148510915.USD","LU1934453819.USD","BK0188","000686","BK0060","BK0239","LU1979443071.USD","LU1064131003.USD","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662099855","title":"科伦药业（002422）披露控股股东部分股份质押及解除质押公告，8月28日股价下跌1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662099855","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662099855?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:03","pubTimestamp":1787925796,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，科伦药业报收于41.75元，较前一交易日下跌1.25%，最新总市值为664.15亿元。该股当日开盘42.0元，最高42.31元，最低41.54元，成交额达7.21亿元，换手率为1.33%。公告显示，公司控股股东刘革新先生近日办理了部分股份解除质押及新质押业务。本次质押后，刘革新先生累计质押股份占其所持股份比例为23.29%。相关股份不存在业绩补偿义务，亦未出现平仓风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800053443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU2148510915.USD","BK0060","LU1064131003.USD","LU1934453819.USD","BK0239","002422","LU1979443071.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662396660","title":"科伦药业（002422）2026年中报简析：净利润同比增长12.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662396660","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662396660?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:27","pubTimestamp":1787869674,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期科伦药业发布2026年中报。根据财报显示，科伦药业净利润同比增长12.71%。截至本报告期末，公司营业总收入88.39亿元，同比下降2.69%，归母净利润11.28亿元，同比上升12.71%。按单季度数据看，第二季度营业总收入45.79亿元，同比下降2.43%，第二季度归母净利润6.74亿元，同比上升61.89%。去年的净利率为10.14%，算上全部成本后，公司产品或服务的附加值一般。本文数据来源于科伦药业2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800011398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662746372","title":"股市必读：科伦药业新发布《关于“质量回报双提升”行动方案的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662746372","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662746372?lang=zh_cn&edition=full","pubTime":"2026-08-27 01:06","pubTimestamp":1787763983,"startTime":"0","endTime":"0","summary":"公司公告汇总关于“质量回报双提升”行动方案的进展公告科伦药业披露“质量回报双提升”行动方案2026年上半年实施进展。关于变更公司会计政策的公告四川科伦药业股份有限公司根据财政部发布的《企业会计准则解释第19号》和《企业会计准则解释第20号》相关规定，对会计政策进行变更。2026年半年度非经营性资金占用及其他关联资金往来情况汇总表四川科伦药业股份有限公司披露2026年半年度非经营性资金占用及其他关联资金往来情况汇总表。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700003277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","LU1064131003.USD","LU1064130708.USD","LU2148510915.USD","BK0239","LU1979443071.USD","002422","LU1934453819.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662171588","title":"科伦药业最新公告：上半年净利润11.28亿元同比增长12.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662171588","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662171588?lang=zh_cn&edition=full","pubTime":"2026-08-26 19:17","pubTimestamp":1787743051,"startTime":"0","endTime":"0","summary":"科伦药业(002422.SZ)公告称，公司发布2026年半年度报告，实现营业收入88.39亿元，同比下降2.7%；归属于上市公司股东的净利润11.28亿元，同比增长12.71%。公司拟每10股派发现金红利1.26元(含税)。注：公司Q2净利润6.74亿，Q1净利润4.54亿，据此计算，Q2净利润环比增长48%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600043355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002422"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791083194055,"stockEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":0.0067},{"period":"3month","weight":-0.0872},{"period":"6month","weight":0.163},{"period":"1year","weight":0.1318},{"period":"ytd","weight":0.4114}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川科伦药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"38356人(较上一季度减少6.56%)","perCapita":"33855股","listingDate":"2010-06-03","address":"四川省成都市新都区新都卫星城工业开发区南二路","registeredCapital":"159078万元","survey":" 四川科伦药业股份有限公司的主营业务是大容量注射剂（输液）、小容量注射剂（水针）、注射用无菌粉针（含分装粉针及冻干粉针）、片剂、胶囊剂、颗粒剂、口服液、腹膜透析液等27种剂型药品及中间体、原料药、医药包材等产品的研发、生产和销售。公司的主要产品是大容量注射剂（输液）、小容量注射剂（水针）、注射用无菌粉针（含分装粉针及冻干粉针）、片剂、胶囊剂、颗粒剂、口服液、腹膜透析液。公司位列“中国医药制造业百强”和“中国制造业500强”，荣登“中国化药企业百强”和“BigPharma企业创新力十强”等榜单。","listedPrice":83.36},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科伦药业(002422)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科伦药业(002422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科伦药业,002422,科伦药业股票,科伦药业股票老虎,科伦药业股票老虎国际,科伦药业行情,科伦药业股票行情,科伦药业股价,科伦药业股市,科伦药业股票价格,科伦药业股票交易,科伦药业股票购买,科伦药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科伦药业(002422)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科伦药业(002422)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}